Berberine
Berberine Hydrochloride · also known as Berberine, Dihydroberberine
Human clinical studies show that berberine can lower blood glucose and blood lipids, and this outcome evidence is fairly reliable. Its proposed molecular mechanisms, such as AMPK activation, come mostly from animal and cell experiments. Whether the same activation occurs in target tissues after usual oral doses has not been measured directly.
Clinical uses and human evidence
Blood sugar and insulin resistance
High LDL cholesterol
Studies (2)
- Blais 2023 · Drugs · Meta-analysis · n=1788 — Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
- Lei 2026 · JAMA Netw Open · RCT · n=337 — Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial
High triglycerides
Irritable bowel syndrome
All-cause mortality risk
Body weight and body fat
Fatty liver and liver enzymes
Studies (2)
- Nie 2024 · J Transl Med · Meta-analysis · n=811 — The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
- Lei 2026 · JAMA Netw Open · RCT · n=337 — Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial
Polycystic ovary syndrome
High blood pressure
Studies (2)
- Zamani 2022 · Front Nutr · Meta-analysis — The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis
- Liu 2025 · Front Pharmacol · Meta-analysis — Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials
Mechanisms of action
AMPK sensing of cellular energy deficit and metabolic reprogramming
Berberine can mildly inhibit the mitochondrial respiratory chain, which raises the intracellular AMP/ATP ratio and in turn activates AMPK. AMPK activation has been observed in rat skeletal muscle studies. However, whether the same happens in target tissues after usual oral dosing in humans has not been measured directly, and the drop in blood glucose does not by itself prove this mechanism.
Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair
In mouse intestinal injury models and some cell models, berberine can improve the epithelial barrier, but a better barrier does not always come with higher total levels of tight junction proteins. Effects in humans and dependence on MLCK have yet to be verified, and there is no direct confirmation from intestinal biopsies.
Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
In animal and cell inflammation models, berberine can inhibit TLR4 and NF-κB signaling and reduce the release of pro-inflammatory factors. Pathway inhibition after oral intake in humans has not been directly confirmed, and human cell experiments with berberine added in vitro are not equivalent to oral trials.
Safety and drug interactions
Low blood sugar risk
Human trials confirmed it can lower blood sugar. Each of these may lower blood sugar. Taken together, especially on an empty stomach or alongside antidiabetic drugs, they may cause low blood sugar symptoms such as palpitations, shaking and cold sweats.
Inhibition of drug metabolism (CYP3A4 and others)
Inhibits CYP3A4, CYP2D6, CYP2C9 and P-glycoprotein. Each of these can inhibit the liver enzymes that metabolize drugs (mainly CYP3A4) or drug transporter proteins, raising blood levels of some prescription drugs.
With Sedative-hypnotics Needs attention
Berberine inhibits the metabolism of some sleep medications. In a small study, midazolam blood levels rose by about 40% after continuous berberine use, which may strengthen sedation. Its effect on other sleep medications is unclear.
With Digoxin Needs attention
Berberine can inhibit P-glycoprotein and may raise blood levels of digoxin. The evidence so far comes mainly from animal studies. If the two are taken together, monitoring digoxin levels is recommended.
Related lab tests
Fasting glucose and hemoglobin A1c Recheck while taking
Berberine lowers blood sugar. People with diabetes who use it should recheck HbA1c after about 3 months. People also taking glucose-lowering drugs should check blood sugar sooner and more often, and watch for low blood sugar.